Diabetic Retinopathy Market share to reach USD 11.1 billion by 2023
shared by jueekate on Feb 01
6
views
0
faves
0
comments
Get more information @ http://bit.ly/2kq4uSV
Some of the key players in the diabetic retinopathy market include Bayer, Valeant Pharmaceutical, Novartis, F. Hoffmann-La Roche, Alimera Science, Abbott ...
Laboratories, Pfizer, Regeneron Pharmaceutical, and Ampio Pharmaceuticals. Other notable players include Actavis, Boehringer Ingelheim, Kowa group, BCN peptides, ThromboGenics, Bausch & Lomb, iCo Therapeutics, Quark Pharmaceuticals and Vitreoretinal Technologies among others.
Source
https://www....thy-marketCategory
HealthGet a Quote
